NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

乳酸林格注射液的全球市場:2021年∼2028年

Global Lactated Ringers Injection Market - 2021-2028

出版商 DataM Intelligence 商品編碼 1023073
出版日期 內容資訊 英文 180 Pages
商品交期: 約2個工作天內
價格
乳酸林格注射液的全球市場:2021年∼2028年 Global Lactated Ringers Injection Market - 2021-2028
出版日期: 2021年08月12日內容資訊: 英文 180 Pages
簡介

乳酸林格注射液,低血壓或低血液量的患者補充喪失的電解質和水分。還有乳酸林格注射液,也用於讓體內的pH值上升的鹼化劑。

本報告提供全球乳酸林格注射液市場相關調查分析,產業分析,各市場區隔的市場分析,競爭情形,主要企業等相關的系統性資訊。

目錄

第1章 乳酸林格注射液市場:調查手法、範圍

第2章 乳酸林格注射液市場:市場定義、概要

第3章 乳酸林格注射液市場:摘要整理

第4章 乳酸林格注射液市場:市場動態

  • 影響市場的要素
    • 促進因素
    • 阻礙因素
    • 機會
    • 影響分析

第5章 乳酸林格注射液市場:產業分析

  • 波特的五力分析
  • 流行病學分析
  • 供應鏈分析
  • 價格分析
  • 法規分析
  • 償付分析
  • 未滿足需求

第6章 乳酸林格注射液市場:COVID-19分析

  • 對市場的COVID-19分析
  • COVID-19的價格動態
  • 需求與供給的頻譜
  • 大流行時的市場相關的政府舉措
  • 製造商策略性舉措
  • 結論

第7章 乳酸林格注射液市場:各類型

  • 簡介
  • 1,000ml
  • 100ml

第8章 乳酸林格注射液市場:各用途

  • 簡介
  • 人用
  • 動物用

第9章 乳酸林格注射液市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 南美
  • 亞太地區
  • 中東、非洲

第10章 乳酸林格注射液市場:競爭情形

  • 主要的發展與策略
  • 企業佔有率分析
  • 產品基準
  • 值得注意的主要企業
  • 有顛覆性技術的企業
  • Start-Ups企業

第11章 乳酸林格注射液市場:企業簡介

  • B. Braun Medical Inc
  • ICU Medical
  • Jiangxi Tianxin Pharmaceutical Co. Ltd.
  • BAXTER
  • Huazhong Pharmaceutical
  • Vedco Inc
  • Dechra
  • Nanjing Pharmaceutical Factory Co. Ltd.
  • Wuyao Pharmaceutical
  • Shanghai Hegno Pharmaceutical Holding Co., Ltd等

第12章 乳酸林格注射液市場:DataM

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: DMPH3868

Lactated Ringers Injection Market Overview

The lactated ringers injection market size was valued at US$ XX billion in 2020 and is estimated to reach US$ XX billion by 2028, growing at a CAGR of XX % during the forecast period (2021-2028).

Lactated Ringer's injection replaces electrolyte and water loss in patients with low blood pressure or low blood volume. Lactated Ringer's injection is also used as an alkalinizing agent, which increases the pH level of the body.

Lactated Ringers Injection Market Dynamics

After trauma, short-term fluid replacement and dehydration, and replacement of fluids and electrolytes will drive the Lactated Ringers Injection Market

After trauma, short-term fluid replacement and dehydration will drive the lactated ringers injection market

Ringer Lactate R Injection is used for short-term fluid replacement and dehydration. It comprises four medicines: sodium chloride, sodium lactate, potassium chloride, and calcium chloride that help replenish fluid loss. Thus, it treats hypovolemia that can result due to dehydration, injury, or burns. Ringer Lactate Injection must be administered under the supervision of a healthcare professional. Patients should not take it if they have any known allergy to this injection. Doctor may check blood pressure and suggest to get regular blood tests done while using this injection.

Fluid resuscitation in trauma patients, aims to prevent a cardiac arrest due to severe hypovolaemia and achieve a satisfying level of mean arterial pressure to ensure adequate tissue perfusion. In trauma patients fluid resuscitation is indicated for traumatic hemorrhage, sympatholysis due to sedation or spinal injury and vasoplegia due to inflammation (tissue attrition and ischaemiareperfusion). Recently, lactate solutions have been proposed as an alternative to mannitol in trauma brain injury patients.

The replacement of fluids and electrolytes will drive the lactated ringers injection market

In lactated ringer's injection 5% dextrose provides electrolytes, calories and is a water source for hydration. Depending on the clinical condition of patient it is capable of inducing diuresis. This solution contains lactate which produces a metabolic alkalinizing effect. It restores fluid and electrolyte balances, produces diuresis, and acts as an alkalizing agent (reduces acidity).

In patients with low blood pressure or low blood volume lactated ringer's injection is used to replace water and electrolyte loss. As an alkalinizing agent it is used to increase the pH level of the body. It is more beneficial than a saline solution as it doesn't remain in the body for as long and is less likely to cause fluid overload.

The addition of lactate reduces acidity as the body converts it into bicarbonate, a base element that helps regulate its pH balance. Acidosis commonly occurs when the liquid portion of the blood is too low, a condition called hypovolemia.

Side effects related to its use and route of administration will hamper the lactated ringers injection market

There is a fear of ringer's lactate worsening lactic acidosis and causing hyperkalemia. Ringer's lactate includes a concentration of potassium four mEq/L. Logically, if giving an additional hyperkalemic potassium a hyperkalemic would worsen hyperkalemia, this is not correct. Hyperkalemia in patients may worsen with metabolic acidosis. Large-volume IV administration of normal saline may consequently give patients a hyperchloremic non-anion gap metabolic acidosis. Ringer's lactate does not have this effect. It also has a calcium concentration which prohibits the use of it as a diluent for blood transfusions. As an anticoagulant some blood products use citrate and when mixed with calcium it leads to the precipitation of calcium citrate. It may cause clotting and obstruction of the IV line.

In IV fluid administration, there is a possibility of edema and swelling. At-risk patients are those with chronic kidney disease, congestive heart failure, liver cirrhosis and hypoalbuminemia. During IV administration, these patients must be monitored with serial physical exams to determine if they are becoming clinically hypervolemic.

COVID-19 Impact Analysis

COVID-19 has affected the healthcare industry. To curb its growth, government-imposed lockdown. People are fearful they will experience occupational effects and adverse health from the COVID-19 pandemic. This affects the lactated ringers injection market as many pharmaceutical industries have stopped manufacturing units.

Lactated Ringers Injection Market Segment Analysis

1000 ml segment will dominate the lactated ringers injection market

Lactated Ringer's Injection, USP, 1000 mL VIAFLEX Plastic Container. Lactated Ringers Injection, USP is a sterile, nonpyrogenic solution for fluid and electrolyte replenishment in single-dose containers for intravenous administration. It contains no antimicrobial agents. Each Lactated Ringer's injection USP of 100 mL contains sodium chloride 600 mg, sodium lactate, anhydrous 310 mg, potassium chloride 30 g and calcium chloride, dihydrate 20 mg.

Penn Care manufactures IV Fluids, Lactated Ringers Injection USP, 1000 mL.

The human medical use segment will dominate the lactated ringers injection market

Lactated Ringer's solution can be received by both adults and children. It is often the IV solution of choice if one has sepsis or infection so severe that body's acid-base balance is thrown off. Doctors also use lactated Ringer's as an irrigating solution. The solution is sterile. It can therefore be used to wash out a wound. It can also be used during surgery to irrigate the bladder or a surgical site. This helps to wash away bacteria or make a surgical site easier to see. Manufacturers don't intend for people to drink lactated Ringer's solution. It's only meant for irrigation or IV use. Lactated Ringer's Injection USP is nonpyrogenic, sterile and contains no antimicrobial agents or bacteriostatic. This product is intended for intravenous administration in a single-dose container.

Lactated Ringer's Injection USP is a source of water for hydration and provides electrolytes. Depending on the the patients clinical condition it induces diuresis. This solution produces a metabolic alkalinizing effect because it contains lactate. The major cation of the extracellular fluid sodium, functions primarily to control fluid balance, water distribution and osmotic pressure of body fluids. Sodium is also associated with chloride and bicarbonate in the regulation of the acid-base equilibrium of body fluid. Potassium, the principal cation of intracellular fluid, participates in carbohydrate utilization and protein synthesis and is critical in regulating nerve conduction and muscle contraction, particularly in the heart.

Lactated Ringers Injection Market Geographical Analysis

North America region will dominate the lactated ringers injection market

This region will dominate the lactated ringers injection market with increased research and development activity and major key player's presence.

The US FDA has announced that ICU Medical voluntarily recalls a single lot of Lactated Ringer's Injection, with the lot number 07-514-FW, nationwide in the US. According to the agency, the products are being recalled at the hospital and user level due to particulate matter identified as iron oxide. Through a single customer complaint ICU Medical became aware of this issue.

An American-managed company AdvaCare is a GMP manufacturer of Ringer Lactate infusion. Ringer lactate infusion is a non-pyrogenic, sterile solution used for electrolyte replacement. It has no antimicrobial agents and is hence not used to treat any microbial infections. Ringer lactate is also used in the treatment of burns, gastrointestinal fluid loss and acute blood loss.

Lactated Ringers Injection Market Competitive Landscape

Major key players in the ICU Medical, B. Braun Medical Inc, Baxter, Vedco Inc, Dechra, Huazhong Pharmaceutical, Shanghai Hegno Pharmaceutical Holding Co., Ltd., and Nanjing Pharmaceutical Factory Co. Ltd.

Lactated Ringers Injection Market Key Companies to Watch

B. Braun Medical Inc

Overview: A leader in infusion therapy and pain management, B. Braun Medical Inc. develops, manufactures, and markets innovative services and medical products to the healthcare industry. Other key product areas include pharmacy admixture, nutrition and dialysis. The company is committed to eliminate preventable treatment errors and enhancing patient, clinician and environmental safety. B. Braun Medical is headquartered in Bethlehem, PA. It is part of the B. Braun Group of Companies in the U.S., including B. Braun Interventional Systems, Aesculap® and CAPS®.

Product Portfolio: The company is involved in manufacturing IV Therapy, Infusion Systems, Vascular Access, Regional Anesthesia, and Pharmacy.

Key Development: On 25th February 2019, B. Braun Medical Inc. has announced the acquisition of Medisystems®' Streamline® Bloodlines business. The acquired bloodline systems will include the Streamline Bloodline for the Dialog+® hemodialysis system, Streamline Bloodline for the Fresenius Medical Care hemodialysis system, and Streamline Bloodline Long for the Fresenius Medical Care hemodialysis system.

Why Purchase the Report?

  • Visualize the composition of the lactated ringers injection market Segmentation By Type and By Application highlighting the key commercial assets and players.
  • Identify commercial opportunities in lactated ringers injection market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of lactated ringers injection market- level 4/5 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  • Product mapping in excel for the key product of all major market players

The lactated ringers injection market report would provide an access to an approx. 53 market data table, 40 figures and 200 pages.

Target Audience

  • Service Providers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturers

Market Segmentation

Lactated Ringers Injection Market- By Type

  • 1000 ML
  • 100 ML

Lactated Ringers Injection Market- By Application

  • Human Medical
  • Animal Medical

Lactated Ringers Injection Market- By Region

  • North America
  • South America
  • Europe
  • Asia
  • Middle East & Africa

Table of Contents

1. Lactated Ringers Injection Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Lactated Ringers Injection Market- Market Definition and Overview

3. Lactated Ringers Injection Market- Executive Summary

  • 3.1. Market Snippet By Type
  • 3.2. Market Snippet By Application
  • 3.3. Market Snippet By Region

4. Lactated Ringers Injection Market-Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. After trauma, short-term fluid replacement and dehydration will drive the lactated ringers injection market
      • 4.1.1.2. The replacement of fluids and electrolytes will drive the lactated ringers injection market
    • 4.1.2. Restraints:
      • 4.1.2.1. Side effects related to its use and route of administration will hamper the lactated ringers injection market
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Lactated Ringers Injection Market- Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Epidemiology Analysis
  • 5.3. Supply Chain Analysis
  • 5.4. Pricing Analysis
  • 5.5. Regulatory Analysis
  • 5.6. Reimbursement Analysis
  • 5.7. Unmet Needs

6. Lactated Ringers Injection Market- COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. Lactated Ringers Injection Market- By Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type Segment
    • 7.1.2. Market Attractiveness Index, By Type Segment
  • 7.2. 1000 ML *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 7.3. 100 ML

8. Lactated Ringers Injection Market- By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
    • 8.1.2. Market Attractiveness Index, By Application Segment
  • 8.2. Human Medicals *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 8.3. Animal Medical

9. Lactated Ringers Injection Market- By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028, By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 9.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.2.5.1. U.S.
      • 9.2.5.2. Canada
      • 9.2.5.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 9.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.3.5.1. Germany
      • 9.3.5.2. U.K.
      • 9.3.5.3. France
      • 9.3.5.4. Italy
      • 9.3.5.5. Spain
      • 9.3.5.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.4.5.1. Brazil
      • 9.4.5.2. Argentina
      • 9.4.5.3. Rest of South America
  • 9.5. Asia Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.5.5.1. China
      • 9.5.5.2. India
      • 9.5.5.3. Japan
      • 9.5.5.4. Australia
      • 9.5.5.5. Rest of Asia Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

10. Lactated Ringers Injection Market- Competitive Landscape

  • 10.1. Key Developments and Strategies
  • 10.2. Company Share Analysis
  • 10.3. Product Benchmarking
  • 10.4. Key Companies to Watch
  • 10.5. Company with disruptive technology
  • 10.6. Start Up Companies

11. Lactated Ringers Injection Market- Company Profiles

  • 11.1. B. Braun Medical Inc*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Key Highlights
    • 11.1.4. Financial Overview
  • 11.2. ICU Medical
  • 11.3. Jiangxi Tianxin Pharmaceutical Co. Ltd.
  • 11.4. BAXTER
  • 11.5. Huazhong Pharmaceutical
  • 11.6. Vedco Inc
  • 11.7. Dechra
  • 11.8. Nanjing Pharmaceutical Factory Co. Ltd.
  • 11.9. Wuyao Pharmaceutical
  • 11.10. Shanghai Hegno Pharmaceutical Holding Co., Ltd

LIST NOT EXHAUSTIVE

12. Lactated Ringers Injection Market- DataM

  • 12.1. Appendix
  • 12.2. About Us and Services
  • 12.3. Contact Us